We wish to inform to the Exchange that TRIDENT MEDIQUIP LIMITED (TML) (CIN: U33309GJ2019PLC110421), a subsidiary company has made Private Placement of equity shares to other shareholders. ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Trident Lifeline Ltd's subsidiary, Trident Mediquip Limited (TML), has issued equity shares through a private placement to other shareholders. As a result, Trident Lifeline's stake in TML has been diluted from 60.04% to 57.34%. TML operates in the pharmaceuticals and chemicals industry, with a turnover of Rs. 21.29 crore in FY25 (down from Rs. 28.77 crore in FY23). The paid-up share capital of TML is Rs. 9.77 crore, and the transaction is classified as a related party transaction carried out at arm's length.
This is a minor dilution event at the subsidiary level and does not directly impact Trident Lifeline's promoter or shareholder structure. Investors should note that TML remains a subsidiary and continues to contribute to the company's consolidated financials, though TML's turnover has been declining over the past three years.